A grey photography background with a formal headshot photo of Muhammed Murtaza, MBBS, PhD, wearing a dark blue suit and tie.

Muhammed Murtaza, MBBS, PhD

Associate Professor

  • Division of Surgical Oncology
  • Director of the Center for Human Genomics and Precision Medicine

murtaza@surgery.wisc.edu

Education

  • Bachelor of Medicine and Bachelor of Surgery, Aga Khan University Medical College
  • PhD, Medical Science, Cancer Research UK Cambridge Institute, University of Cambridge

Research Interests

Dr. Murtaza was awarded a three-year, $1 million Cooperative Award (UH3) from the National Cancer Institute. Read more here.

Dr. Murtaza and Dr. Zafar were awarded a $50,000 Translational Basic and Clinical Research Pilot Award from the UW Institute for Clinical and Translational Research and the UW Carbone Cancer Center. Read more here.

Recent Publications

  • Comparative analysis of cell-free DNA fragmentation patterns in canines with sarcoma and tumor-free canines and humans.
    Favaro PF, Wang Y, McDonald BR, Wang TX, Jadhav S, Cheng HH, Marcinak CT, Pan X, Murtaza M
    Cancer Res Commun 2026 Jan 16;
    [PubMed ID: 41544207]

  • Fragment end motif analysis to distinguish pathogens from contaminants in enriched plasma microbial DNA.
    Zhang H, Dominguez EG, Junak M, Murtaza M, Pepperell CS, Kisat MT
    medRxiv 2025 Nov 07;
    [PubMed ID: 41282688]

  • Detection of PIK3CA Mutations in Anal Dysplasia.
    Johnson HR, Dietmann EC, Praska CE, Dennison KL, McGregor SM, Suter W, Leverson G, Murtaza M, Carchman EH
    J Surg Res 2025 Nov; 315: 106-112
    [PubMed ID: 41033178]

  • Efficient nonviral integration of large transgenes into human T cells using Cas9-CLIPT.
    Tommasi A, Cappabianca D, Bugel M, Gimse K, Lund-Peterson K, Shrestha H, Arutyunov D, Williams JA, Police SR, Indurthi V, Davis SZ, Murtaza M, Capitini CM, Saha K
    Mol Ther Methods Clin Dev 2025 Mar 13; 33(1): 101437
    [PubMed ID: 40123742]

  • Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.
    Shankar K, Zingler-Hoslet I, Tabima DM, Zima S, Shi L, Gimse K, Forsberg MH, Katta V, Davis SZ, Maldonado D, Russell BE, Murtaza M, Tsai SQ, Ayuso JM, Capitini CM, Saha K
    Mol Ther 2025 Mar 05; 33(3): 1014-1030
    [PubMed ID: 39815622]

All Publications on PubMed